Global Frontier Investments LLC Amryt Pharma PLC Transaction History

Global Frontier Investments LLC

Previous 0 NaN%

Previous $0 NaN%

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	0 New	0 $0
Q4 2023 Mar 13, 2024	BUY	N/A	0 New	0 $0
Q3 2023 Dec 06, 2023	BUY	N/A	0 New	0 $0
Q2 2023 Aug 16, 2023	BUY	$0.0 - $14.7 $0 - $0	0 New	0 $0
Q1 2023 May 12, 2023	SELL	$7.0 - $14.77 $3.54 Million - $7.46 Million	-505,000 Closed	0 $0

Q3 2022 Nov 14, 2022	BUY	$6.8 - $8.01 $476,000 - $560,700	70,000 Added 16.09%	505,000 $3.5 Million
Q4 2021 Feb 10, 2022	BUY	$9.44 - $12.24 $236,000 - $306,000	25,000 Added 6.1%	435,000 $4.7 Million
Q3 2021 Nov 15, 2021	BUY	$9.63 - $12.47 $914,850 - $1.18 Million	95,000 Added 30.16%	410,000 $4.94 Million
Q2 2021 Aug 17, 2021	BUY	$10.9 - $14.29 $2.07 Million - $2.72 Million	190,000 Added 152.0%	315,000 $3.82 Million
Q3 2020 Nov 10, 2020	BUY	$10.8 - $13.5 $1.35 Million - $1.69 Million	125,000 New	125,000 $1.55 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Global Frontier Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Global Frontier Investments LLC with notifications on news.